NDC Package 64896-967-23 Crexont

Carbidopa And Levodopa Capsule, Extended Release Oral - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
64896-967-23
Package Description:
1 BOTTLE in 1 CARTON / 120 CAPSULE, EXTENDED RELEASE in 1 BOTTLE
Product Code:
Proprietary Name:
Crexont
Non-Proprietary Name:
Carbidopa And Levodopa
Substance Name:
Carbidopa; Levodopa
Usage Information:
CREXONT is indicated for the treatment of Parkinson's disease, post-encephalitic parkinsonism, and parkinsonism that may follow carbon monoxide intoxication or manganese intoxication in adults.
11-Digit NDC Billing Format:
64896096723
NDC to RxNorm Crosswalk:
  • RxCUI: 2690259 - carbidopa 35 MG / levodopa 140 MG Extended Release Oral Capsule
  • RxCUI: 2690259 - carbidopa 35 MG / L-DOPA 140 MG Extended Release Oral Capsule
  • RxCUI: 2690265 - CREXONT 35 MG / 140 MG Extended Release Oral Capsule
  • RxCUI: 2690265 - carbidopa 35 MG / levodopa 140 MG Extended Release Oral Capsule [Crexont]
  • RxCUI: 2690265 - carbidopa 35 MG / L-DOPA 140 MG Extended Release Oral Capsule [Crexont]
Product Type:
Human Prescription Drug
Labeler Name:
Amneal Pharmaceuticals Llc
Dosage Form:
Capsule, Extended Release - A solid dosage form in which the drug is enclosed within either a hard or soft soluble container made from a suitable form of gelatin, and which releases a drug (or drugs) in such a manner to allow a reduction in dosing frequency as compared to that drug (or drugs) presented as a conventional dosage form.
Administration Route(s):
Oral - Administration to or by way of the mouth.
Active Ingredient(s):
Sample Package:
Yes
FDA Application Number:
NDA217186
Marketing Category:
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date:
08-09-2024
Listing Expiration Date:
12-31-2026
Exclude Flag:
N
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Other Product Packages

The following packages are also available for this product:

NDC Package CodePackage Description
64896-967-161 BOTTLE in 1 CARTON / 120 CAPSULE, EXTENDED RELEASE in 1 BOTTLE

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 64896-967-23?

The NDC Packaged Code 64896-967-23 is assigned to a package of 1 bottle in 1 carton / 120 capsule, extended release in 1 bottle of Crexont, a human prescription drug labeled by Amneal Pharmaceuticals Llc. The product's dosage form is capsule, extended release and is administered via oral form.

Is NDC 64896-967 included in the NDC Directory?

Yes, Crexont with product code 64896-967 is active and included in the NDC Directory. The product was first marketed by Amneal Pharmaceuticals Llc on August 09, 2024 and its listing in the NDC Directory is set to expire on December 31, 2026 if the product is not updated or renewed by the manufacturer.

What is the 11-digit format for NDC 64896-967-23?

The 11-digit format is 64896096723. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
5-3-264896-967-235-4-264896-0967-23